Vivere Health
Vivere Health | It's About Life
About Vivere Health
Vivere Health, founded in 2010, operated as a strategic partner for fertility specialists, focusing on enhancing and expanding fertility practices. The company was the creation of healthcare entrepreneur Joe Cashia, who served as the initial CEO, in partnership with private equity firm LLR Partners and physicians Dr. Jimmy Gill and Dr. Gus Haddad of The Houston Fertility Institute. Cashia brought previous experience from founding and growing National Renal Alliance, a successful dialysis provider, seeking to apply a similar physician joint venture model to the fertility sector.
The firm’s business model centered on establishing joint-venture partnerships with reproductive endocrinologists to develop and manage ambulatory surgery centers (ASCs) and in-vitro fertilization (IVF) laboratories. Vivere provided capital investment and a suite of operational support services, which included marketing, back-office administration, and pharmacy services. This structure allowed physicians to focus on clinical care and improving patient outcomes while Vivere managed the business and strategic growth aspects, such as developing new practice locations to increase market share. The company's specialized centers were designed to handle the specific needs of women's health, aiming to provide a more efficient and comfortable patient environment than a traditional hospital setting.
Shortly after its formation, Vivere Health began its expansion by acquiring Piney Point Surgical Center and Houston Fertility Laboratory. Over the years, it grew into one of the largest companies in the fertility industry, operating a network of clinics and centers across several U.S. states, including Texas, Florida, and Tennessee. A significant milestone in the company's history was its acquisition by Prelude Fertility in a deal announced in October 2017 and finalized in December 2017. This acquisition integrated Vivere's 22 locations into Prelude's expanding national network, enhancing Prelude's scale and back-office capabilities. At the time of the acquisition, Vivere was also operating egg banking services and a mail-order pharmacy focused on fertility patients.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Oct 2017 | $0 | — | Prelude Fertility | — |
| LATE VC✓Equity / VC | Nov 2010 | $23M | $92M | LLR Partners | — |
Growth signals
Latest recorded traffic for Vivere Health is 3.8K monthly website visits, up 171.4% over the last three months.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Vivere Health in the Franklin ecosystem
The Vivere Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later1 investor entered at this stage
LLR Partners
Other known investors1 additional known investor
Prelude Fertility
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Vivere Health on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vivere Health’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









